Logo-bi
Bioimpacts. 2017;7(3): 193-198. doi: 10.15171/bi.2017.22
PMID: 29159146        PMCID: PMC5684510

Original Research

Lactobacillus plantarum induces apoptosis in oral cancer KB cells through upregulation of PTEN and downregulation of MAPK signalling pathways

Abbas Asoudeh-Fard 1,2, Abolfazl Barzegari 1, Alireza Dehnad 2,3, Sepideh Bastani 1, Asal Golchin 1, Yadollah Omidi 1.4 * ORCID

Cited by CrossRef: 61

1- Praveen Z, Choi S, Lee J, Park J, Oh H, Kwon I, Park J, Kim M. Oral Microbiome and CPT1A Function in Fatty Acid Metabolism in Oral Cancer. IJMS. 2024;25(20):10890 [Crossref]
2- Sami A, Elimairi I, Stanton C, Ross R, Ryan C. The Role of the Microbiome in Oral Squamous Cell Carcinoma with Insight into the Microbiome–Treatment Axis. IJMS. 2020;21(21):8061 [Crossref]
3- Mathew R, Babu A. Probiotics and oral cancer: Old strain in a new bottle?. 2023;6(4):625 [Crossref]
4- Mivehchi H, Eskandari-Yaghbastlo A, Pour Bahrami P, Elhami A, Faghihinia F, Nejati S, Kazemi K, Nabi Afjadi M. Exploring the role of oral bacteria in oral cancer: a narrative review. Discov Onc. 2025;16(1) [Crossref]
5- Shen X, Zhang B, Hu X, Li J, Wu M, Yan C, Yang Y, Li Y. Neisseria sicca and Corynebacterium matruchotii inhibited oral squamous cell carcinomas by regulating genome stability . Bioengineered. 2022;13(6):14094 [Crossref]
6- Xiaogang H, Sharma M, saif I, Ali G, Li X, Salama E. The role of nutrition in harnessing the immune system: a potential approach to prevent cancer. Med Oncol. 2022;39(12) [Crossref]
7- Herrera-Cardoso E, Tapia-Cervantes K, Cepeda-Negrete J, Gutiérrez-Vargas S, León-Galván M. Isolation and identification of Lactobacillus species from gut microbiota of Aegiale hesperiaris (Lepidoptera: Hesperiidae) larvae. 2025;372 [Crossref]
8- Huang Z, Zhu J, Bu X, Lu S, Luo Y, Liu T, Duan N, Wang W, Wang Y, Wang X. Probiotics and prebiotics: new treatment strategies for oral potentially malignant disorders and gastrointestinal precancerous lesions. npj Biofilms Microbiomes. 2025;11(1) [Crossref]
9- Zhang W, Wang Y, Xu P, Du Y, Guan W, Zhong W. lncRNA DLEU2 Accelerates Oral Cancer Progression via miR-30a-5p/RAP1B Axis to Regulate p38 MAPK Signaling Pathway. Disease Markers. 2022;2022:1 [Crossref]
10- Luo Z, Lv S, Lou F, Yan L, Xu J, Kang N, Dong Y, Jin X. Roles of intralesional bacteria in the initiation and progression of oral squamous cell carcinoma. Cancer Medicine. 2024;13(18) [Crossref]
11- Vasanthi V, Sanjeev K, Rajkumar K, Divya B, Rameshkumar A, Swarup S, Ramadoss R. Immune modulation by probiotics in deterring carcinogenesis with an emphasis on oral cancer: A narrative review. 2023;6(3):425 [Crossref]
12- Barzegari A, Nouri M, Gueguen V, Saeedi N, Pavon‐Djavid G, Omidi Y. Mitochondria‐targeted antioxidant mito‐TEMPO alleviate oxidative stress induced by antimycin A in human mesenchymal stem cells. Journal Cellular Physiology. 2020;235(7-8):5628 [Crossref]
13- Asoudeh-Fard A, Soltanmohammadi F, Kashkouie jahromi M, Javanmardi F, Roosta A, Zareian Jahromi M, Parsaei A. Potential anticancer properties of Tetraselmis suecica extract against oral and colorectal cancer cells. Med Oncol. 2025;42(8) [Crossref]
14- Isazadeh A, Hajazimian S, Shadman B, Safaei S, Babazadeh Bedoustani A, Chavoshi R, Shanehbandi D, Mashayekhi M, Nahaei M, Baradaran B. Anti-Cancer Effects of Probiotic Lactobacillus acidophilus for Colorectal Cancer Cell Line Caco-2 through Apoptosis Induction . Pharm Sci. 2020;27(2):262 [Crossref]
15- Abouelela M, Helmy Y. Next-Generation Probiotics as Novel Therapeutics for Improving Human Health: Current Trends and Future Perspectives. Microorganisms. 2024;12(3):430 [Crossref]
16- Li Q, Hu Y, Zhou X, Liu S, Han Q, Cheng L. Role of Oral Bacteria in the Development of Oral Squamous Cell Carcinoma. Cancers. 2020;12(10):2797 [Crossref]
17- Dadgar-Zankbar L, Mokhtaryan M, Bafandeh E, Javanmard Z, Asadollahi P, Darbandi T, Afifirad R, Dashtbin S, Darbandi A, Ghanavati R. Microbiome and bladder cancer: the role of probiotics in treatment. Future Microbiology. 2025;20(1):73 [Crossref]
18- Bourdillon A, Edwards H. Review of probiotic use in otolaryngology. American Journal of Otolaryngology. 2021;42(2):102883 [Crossref]
19- Liu Y, Niu L, Li N, Wang Y, Liu M, Su X, Bao X, Yin B, Shen S. Bacterial‐Mediated Tumor Therapy: Old Treatment in a New Context. Advanced Science. 2023;10(12) [Crossref]
20- Nair A, Tungare K, De A, Jobby R. Probing the Potential: Exploring Probiotics as a Novel Frontier in Cancer Prevention and Therapeutics . J Environ Pathol Toxicol Oncol. 2024;43(2):77 [Crossref]
21- Ravi A, Muthukrishnan S, Gunasangkaran G, Arumugam V, Shanmugam V, Sakthivel K, Pushpam M, Kaliyaperumal A. Biosynthesis of chitosan encapsulated silver- nanoparticles using Probiotic-Lactobacillus plantarum strain and it's in vitro anticancer assessment on HeLa cells. Medicine in Microecology. 2024;22:100117 [Crossref]
22- Su Mun L, Wye Lum S, Kong Yuiin Sze G, Hock Yoong C, Ching Yung K, Kah Lok L, Gopinath D. Association of Microbiome with Oral Squamous Cell Carcinoma: A Systematic Review of the Metagenomic Studies. IJERPH. 2021;18(14):7224 [Crossref]
23- Gunasangkaran G, Ravi A, Arumugam V, Muthukrishnan S. Preparation, Characterization, and Anticancer Efficacy of Chitosan, Chitosan Encapsulated Piperine and Probiotics (Lactobacillus plantarum (MTCC-1407), and Lactobacillus rhamnosus (MTCC-1423) Nanoparticles. BioNanoSci. 2022;12(2):527 [Crossref]
24- Zangeneh Z, Abdi-Ali A, Khamooshian K, Alvandi A, Abiri R, Taneja V. Bacterial variation in the oral microbiota in multiple sclerosis patients. PLoS ONE. 2021;16(11):e0260384 [Crossref]
25- Singh R, Shadan A, Ma Y. Biotechnological Applications of Probiotics: A Multifarious Weapon to Disease and Metabolic Abnormality. Probiotics & Antimicro Prot. 2022;14(6):1184 [Crossref]
26- Agrawal M, Gaikwad S, Srivastava S, Srivastava S. Research Trend and Detailed Insights into the Molecular Mechanisms of Food Bioactive Compounds against Cancer: A Comprehensive Review with Special Emphasis on Probiotics. Cancers. 2022;14(22):5482 [Crossref]
27- Karami K, Anbari K. Breast Cancer: A Review of Risk Factors and New Insights into Treatment. CCTR. 2021;17(3):207 [Crossref]
28- Altves S, Guclu E, Cinar Ayan I, Bilecen K, Vural H. Lysates from the probiotic bacterium Streptococcus thermophilus enhances the survival of T cells and triggers programmed cell death in neuroblastoma cells. Med Oncol. 2023;40(11) [Crossref]
29- Galeana-Patiño C, Ortiz M, Cariño-Cortés R, López-Santillán I, Castro-Rosas J, Gómez-Aldapa C, Muñoz-Pérez V. Probiotics, as Adjuvant Therapy and Preventive Measure on Progression, and Complications of Head and Neck Cancer. CPB. 2023;24(12):1504 [Crossref]
30- Thakker D, Narayanan R. Arginine deiminase produced by lactic acid bacteria as a potent anti-cancer drug. Med Oncol. 2023;40(6) [Crossref]
31- Maleki Kakelar H, Barzegari A, Hanifian S, Barar J, Omidi Y. Isolation and molecular identification of Lactobacillus with probiotic potential from abomasums driven rennet. Food Chemistry. 2019;272:709 [Crossref]
32- Mohd Fuad A, Amran N, Nasruddin N, Burhanudin N, Dashper S, Arzmi M. The Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics in Oral Cancer Management. Probiotics & Antimicro Prot. 2023;15(5):1298 [Crossref]
33- Davoodvandi A, Fallahi F, Tamtaji O, Tajiknia V, Banikazemi Z, Fathizadeh H, Abbasi-Kolli M, Aschner M, Ghandali M, Sahebkar A, Taghizadeh M, Mirzaei H. An Update on the Effects of Probiotics on Gastrointestinal Cancers. Front Pharmacol. 2021;12 [Crossref]
34- Li T, Hao Y, Tang Y, Liang X. Periodontal Pathogens: A Crucial Link Between Periodontal Diseases and Oral Cancer. Front Microbiol. 2022;13 [Crossref]
35- Al-Asfour A, Bhardwaj R, Karched M. Growth Suppression of Oral Squamous Cell Carcinoma Cells by Lactobacillus Acidophilus. International Dental Journal. 2024;74(5):1151 [Crossref]
36- Su L, Yang R, Sheng Y, Ullah S, Zhao Y, Shunjiayi H, Zhao Z, Wang Q. Insights into the oral microbiota in human systemic cancers. Front Microbiol. 2024;15 [Crossref]
37- Kang S, Nguyen D, Yoo S, Min J. Bacteria and bacterial derivatives as delivery carriers for immunotherapy. Advanced Drug Delivery Reviews. 2022;181:114085 [Crossref]
38- Mayakrishnan V, Kannappan P, Tharmalingam N, Bose R, Madheswaran T, Ramasamy M. Bacterial cancer therapy: A turning point for new paradigms. Drug Discovery Today. 2022;27(8):2043 [Crossref]
39- Alizadeh S, Barzegari A, Esmaeili A, Omidi Y. Designing a light-activated recombinant alpha hemolysin for colorectal cancer targeting. Bioimpacts. 2019;10(3):187 [Crossref]
40- Bagheri S, Rahban M, Bostanian F, Esmaeilzadeh F, Bagherabadi A, Zolghadri S, Stanek A. Targeting Protein Kinases and Epigenetic Control as Combinatorial Therapy Options for Advanced Prostate Cancer Treatment. Pharmaceutics. 2022;14(3):515 [Crossref]
41- Saberpour M, Maqsoodi R, Bakhshi B. Anti-cancer properties of chitosan /Lactobacillus acidophilus secretome nanoparticle on signaling pathways of colorectal cancer in colon adenocarcinoma (Caco-2) cell line. BMC Cancer. 2025;25(1) [Crossref]
42- Soleimanpour S, Hasanian S, Avan A, Yaghoubi A, Khazaei M. Bacteriotherapy in gastrointestinal cancer. Life Sciences. 2020;254:117754 [Crossref]
43- Yaghoubi A, Khazaei M, Jalili S, Hasanian S, Avan A, Soleimanpour S, Cho W. Bacteria as a double-action sword in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2020;1874(1):188388 [Crossref]
44- Maleki-Kakelar H, Dehghani J, Barzegari A, Barar J, Shirmohamadi M, Sadeghi J, Omidi Y. Lactobacillus plantarum induces apoptosis in gastric cancer cells via modulation of signaling pathways in Helicobacter pylori. Bioimpacts. 2019;10(2):65 [Crossref]
45- Sukmana B, Saleh R, Najim M, AL-Ghamdi H, Achmad H, Al-Hamdani M, Taher A, Alsalamy A, Khaledi M, Javadi K. Oral microbiota and oral squamous cell carcinoma: a review of their relation and carcinogenic mechanisms. Front Oncol. 2024;14 [Crossref]
46- Kiaheyrati N, Babaei A, Ranji R, Bahadoran E, Taheri S, Farokhpour Z. Cancer therapy with the viral and bacterial pathogens: The past enemies can be considered the present allies. Life Sciences. 2024;349:122734 [Crossref]
47- Wan Mohd Kamaluddin W, Rismayuddin N, Ismail A, Mohamad Aidid E, Othman N, Mohamad N, Arzmi M. Probiotic inhibits oral carcinogenesis: A systematic review and meta-analysis. Archives of Oral Biology. 2020;118:104855 [Crossref]
48- Gupta K, Nowicki C, Giurini E, Marzo A, Zloza A. Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy. Vaccines. 2021;9(12):1497 [Crossref]
49- Guluarte C, Reyes-Becerril M, Gonzalez-Silvera D, Cuesta A, Angulo C, Esteban M. Probiotic properties and fatty acid composition of the yeast Kluyveromyces lactis M3. In vivo immunomodulatory activities in gilthead seabream (Sparus aurata). Fish & Shellfish Immunology. 2019;94:389 [Crossref]
50- Kijowska J, Grzegorczyk J, Gliwa K, Jędras A, Sitarz M. Epidemiology, Diagnostics, and Therapy of Oral Cancer—Update Review. Cancers. 2024;16(18):3156 [Crossref]
51- Li R, Xiao L, Gong T, Liu J, Li Y, Zhou X, Li Y, Zheng X. Role of oral microbiome in oral oncogenesis, tumor progression, and metastasis. Molecular Oral Microbiology. 2023;38(1):9 [Crossref]
52- Sun W, Ma S, Meng D, Wang C, Zhang J. Advances in research on the intestinal microbiota in the mechanism and prevention of colorectal cancer (Review). Mol Med Rep. 2025;31(5):1 [Crossref]
53- He H, Hao Y, Fan Y, Li B, Cheng L. The interaction between innate immunity and oral microbiota in oral diseases. Expert Review of Clinical Immunology. 2023;19(4):405 [Crossref]
54- Wang S, Shan Y, Zhang S, Zhang L, Jiao Y, Xue D, Zhang L, Yi H. Lactobacillus paracasei subsp. paracasei X12 Strain Induces Apoptosis in HT-29 Cells through Activation of the Mitochondrial Pathway. Nutrients. 2023;15(9):2123 [Crossref]
55- Ali A, Ara A, Kashyap M. Gut microbiota: Role and Association with Tumorigenesis in Different Malignancies. Mol Biol Rep. 2022;49(8):8087 [Crossref]
56- Sankarapandian V, Venmathi Maran B, Rajendran R, Jogalekar M, Gurunagarajan S, Krishnamoorthy R, Gangadaran P, Ahn B. An Update on the Effectiveness of Probiotics in the Prevention and Treatment of Cancer. Life. 2022;12(1):59 [Crossref]
57- Adlakha Y, Chhabra R. The human microbiome: redefining cancer pathogenesis and therapy. Cancer Cell Int. 2025;25(1) [Crossref]
58- Shahbaz A, Mahmood T, Javed M, Abbasi B. Current advances in microbial-based cancer therapies. Med Oncol. 2023;40(7) [Crossref]
59- Singh D, Khan M, Siddique H. Therapeutic implications of probiotics in microbiota dysbiosis: A special reference to the liver and oral cancers. Life Sciences. 2021;285:120008 [Crossref]
60- Saadh M, Allela O, Kareem R, Sanghvi G, Ballal S, Naidu K, Bareja L, Chahar M, Gupta S, Sameer H, Yaseen A, Athab Z, Adil M. Exploring preventive and treatment strategies for oral cancer: Modulation of signaling pathways and microbiota by probiotics. Gene. 2025;952:149380 [Crossref]
61- Yaghoubi A, Khazaei M, Hasanian S, Avan A, C. Cho W, Soleimanpour S. Bacteriotherapy in Breast Cancer. IJMS. 2019;20(23):5880 [Crossref]
62- Petrariu O, Barbu I, Niculescu A, Constantin M, Grigore G, Cristian R, Mihaescu G, Vrancianu C. Role of probiotics in managing various human diseases, from oral pathology to cancer and gastrointestinal diseases. Front Microbiol. 2024;14 [Crossref]
63- Rathikota D, Kattaru S, Potukuchi V, Yeguvapalli S. Role of Lactiplantibacillus plantarum strain RD1 (Lpb RD1) in mitochondria-mediated apoptosis: an in vitro analysis. Arch Microbiol. 2022;204(9) [Crossref]
64- Mrázek J, Mekadim C, Kučerová P, Švejstil R, Salmonová H, Vlasáková J, Tarasová R, Čížková J, Červinková M. Melanoma-related changes in skin microbiome. Folia Microbiol. 2019;64(3):435 [Crossref]
65- Finnicum C, Rahal Z, Hassane M, Treekitkarnmongkol W, Sinjab A, Morris R, Liu Y, Tang E, Viet S, Petersen J, Lorenzi P, Tan L, Petrosino J, Hoffman K, Fujimoto J, Moghaddam S, Kadara H. Pathogenesis of Tobacco-Associated Lung Adenocarcinoma Is Closely Coupled with Changes in the Gut and Lung Microbiomes. IJMS. 2022;23(18):10930 [Crossref]

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons